icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises

icon 2022-11-21
عنوان الدراسة
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises
داعم الدراسة
Global Blood Therapeutics (GBT)
دواء الدراسة
Inclacumab
رقم بروتوكول الدراسة
GBT2104-132
حالة الدراسة
Completed
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
مرحلة الدراسة
3

Comments and Suggestions

For any inquiries or comments about the government services, please fill in the required information.

Last update date: 03/09/2024 at 09:20 AM Saudi Arabia time